Waters this week named Albert Fornace's laboratory at Georgetown University Medical Center one of its Centers of Innovation and recognized Fornace and his fellow GUMC researcher Amrita Cheema for their metabolomics research.
Fornace is a professor of oncology at Georgetown and a professor of biochemistry and molecular and cellular biology at GUMC who studies stress signaling in cancer and other diseases.
With Fornace, Cheema is the co-director of the GUMC metabolomics program.
The Waters Centers of Innovation Program is meant to recognize and support the efforts of scientists using mass spec and LC to make scientific breakthroughs, the company said.
Radient Pharmaceuticals this week appointed Dilek Mir director of business development and investor relations.
Previously, Mir was the founder of ProteaSure, developer of a proteomic in vitro diagnostic for endometrial cancer.
Former president of Myriad Genetics, Gregory Critchfield, has been appointed chairman of the board of directors at Saladax Biomedical. Critchfield was president of Myriad until March 2010.
Previously, he was the chief medical and science officer at Corning Clinical Laboratories, which became Quest Diagnostics. He has also served as an independent director in industry associations and other life science diagnostic product and platform companies, including Integrated Diagnostics, Sera Prognostics, Metamark Genetics, Nodality, Biocius Life Sciences, and BioTrove.